3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
18
Breast Neoplasms
14
Pain
5
Lung Neoplasms
5
Neoplasms
3
Agnosia
3
Thyroid Nodule
2
Thyroid Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Goiter
2
Colorectal Neoplasms
2
Chronic Pain
2
Breast Cancer Female
2
Abdominal Cancer
2
post laminectomy syndrome
1
Uterine Cervical Dysplasia
1
Supratentorial Neoplasms
1
Stomach Neoplasms
1
Respiration Disorders
1
Reperfusion Injury
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Peritoneal Cancer
1
Neuroma
1
Neuralgia
1
Mucositis
1
Liver Neoplasms
1
Leiomyoma
1
Laryngeal Neoplasms
1
Interventions
Gemcitabine
5
130-nm albumin-bound paclitaxel
5
Albumin-Bound Paclitaxel
4
napabucasin
3
Ocoxin
3
Irinotecan
3
Fluorouracil
3
Paclitaxel
2
Oxaliplatin
2
Nivolumab
2
Leucovorin
2
Cyclophosphamide
2
Capecitabine
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
trametinib
1
pralsetinib
1
pembrolizumab
1
ozanimod
1
halofantrine
1
guadecitabine
1
ficlatuzumab
1
Ursodeoxycholic Acid
1
Sorafenib
1
Radiotherapy
1
Pemetrexed
1
Oviposition
1
Nadroparin
1
Lenalidomide
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Digestive System Diseases
×
Bupivacaine
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts